Cargando…
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial
RATIONALE: Pulse glucocorticoid therapy is used in hyperinflammation related to coronavirus disease 2019 (COVID-19). We evaluated the efficacy and safety of pulse intravenous methylprednisolone in addition to standard treatment in COVID-19 pneumonia. METHODS: In this multicentre, randomised, double-...
Ejemplares similares
-
A simplified lung ultrasound approach to detect increased extravascular lung water in critically ill patients
por: Anile, Antonio, et al.
Publicado: (2017) -
Pharmacologicaltreatment of COVID-19: lights and shadows
por: Menzella, Francesco, et al.
Publicado: (2020) -
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review
por: Dolci, Giovanni, et al.
Publicado: (2023) -
Renal Ischemia/Reperfusion Early Induces Myostatin and PCSK9 Expression in Rat Kidneys and HK-2 Cells
por: Barisione, Chiara, et al.
Publicado: (2021) -
COVID-19: general overview, pharmacological options and ventilatory support strategies
por: Menzella, Francesco, et al.
Publicado: (2020)